Contineum Therapeutics, Inc. (CTNM)
11.50
-1.23
(-9.66%)
USD |
NASDAQ |
Sep 29, 16:00
Contineum Therapeutics Market Cap : 432.55M for Sept. 29, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| September 29, 2026 | 432.55M |
| September 28, 2026 | 478.82M |
| September 25, 2026 | 472.42M |
| September 24, 2026 | 469.79M |
| September 23, 2026 | 470.54M |
| September 22, 2026 | 504.02M |
| September 21, 2026 | 509.66M |
| September 18, 2026 | 508.91M |
| September 17, 2026 | 496.87M |
| September 16, 2026 | 517.56M |
| September 15, 2026 | 519.82M |
| September 14, 2026 | 557.43M |
| September 11, 2026 | 557.43M |
| September 10, 2026 | 551.41M |
| September 09, 2026 | 569.47M |
| September 08, 2026 | 599.56M |
| September 04, 2026 | 628.14M |
| September 03, 2026 | 660.87M |
| September 02, 2026 | 648.46M |
| September 01, 2026 | 622.50M |
| August 31, 2026 | 610.84M |
| August 28, 2026 | 641.31M |
| August 27, 2026 | 648.83M |
| August 26, 2026 | 640.18M |
| August 25, 2026 | 641.31M |
| Date | Value |
|---|---|
| August 24, 2026 | 625.51M |
| August 21, 2026 | 646.57M |
| August 20, 2026 | 602.57M |
| August 19, 2026 | 602.57M |
| August 18, 2026 | 545.39M |
| August 17, 2026 | 546.52M |
| August 14, 2026 | 533.73M |
| August 13, 2026 | 575.48M |
| August 12, 2026 | 563.45M |
| August 11, 2026 | 557.43M |
| August 10, 2026 | 545.02M |
| August 07, 2026 | 565.71M |
| August 06, 2026 | 577.37M |
| August 05, 2026 | 574.36M |
| August 04, 2026 | 598.05M |
| August 03, 2026 | 599.18M |
| July 31, 2026 | 582.63M |
| July 30, 2026 | 592.41M |
| July 29, 2026 | 540.88M |
| July 28, 2026 | 532.61M |
| July 27, 2026 | 521.32M |
| July 24, 2026 | 525.65M |
| July 23, 2026 | 537.24M |
| July 22, 2026 | 550.70M |
| July 21, 2026 | 519.67M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Cocrystal Pharma, Inc. | 15.44M |
| CNBX Pharmaceuticals, Inc. | 0.2214M |
| GB Sciences, Inc. | 0.0407M |
| Arvinas, Inc. | 489.75M |
| Fulcrum Therapeutics, Inc. | 282.26M |
Market Cap Related Metrics
| Price to Book Value | 1.805 |
| Price | 11.50 |
| Earnings Yield | -15.11% |